Abstract
Atypical femoral fractures have attracted a great deal of attention and controversy in the osteoporosis community because of their association with prolonged bisphosphonate therapy. The purpose of this article is to review the epidemiologic evidence linking bisphosphonates to atypical fractures and to highlight the potential pathologic mechanisms involved in such fractures. A management plan is provided based on the available evidence.
Original language | English (US) |
---|---|
Pages (from-to) | 137-151 |
Number of pages | 15 |
Journal | Orthopedic Clinics of North America |
Volume | 44 |
Issue number | 2 |
DOIs | |
State | Published - Apr 2013 |
Externally published | Yes |
Keywords
- Atypical femoral fractures
- Atypical fractures
- Bisphosphonate therapy
- Osteoporosis
ASJC Scopus subject areas
- Orthopedics and Sports Medicine